Supplementary Figure S1
Supplementary Figure S1 . Inhibition of XBP1 splicing and RIDD activities of IRE1α by doxorubicin in vitro In vitro RNase reactions with purified recombinant IRE1α and radiolabelled XBP1 or BLOS1 (representing RIDD activity) mRNA were performed in the presence of 0, 0.5, 1, 10, 30, 50, 100 µM doxorubicin. Doxorubicin demonstrated inhibition of IRE1α RNase activity with an IC 50 calculated to be 19.81 ± 1.33 µM for XBP1 splicing and 18.83 ± 3.06 µM for RIDD. 
HT1080, 14h
Tg ( + cells isolated from 6 MM patients were treated with 1 µM doxorubicin for 6 hours then total RNA was extracted and used for qRT-PCR analysis with primers specific for the individual genes.
Results represent average quantities of technical triplicates of the target gene normalized to total β-actin ± c.v. Results of CD138 + cells from both peripheral blood (PB) and bone marrow (BM) of patient 1 are shown.
